Omnicell
OMCL
386 hedge funds and large institutions have $6.7B invested in Omnicell in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 144 increasing their positions, 148 reducing their positions, and 26 closing their positions.
50% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 26
2% more funds holding
Funds holding: 377 → 386 (+9)
1.27% more ownership
Funds ownership: 102.57% → 103.84% (+1.3%)
0% less capital invested
Capital invested by funds: $6.71B → $6.7B (-$7.02M)
3% less repeat investments, than reductions
Existing positions increased: 144 | Existing positions reduced: 148
5% less call options, than puts
Call options by funds: $7.69M | Put options by funds: $8.09M
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$104M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$35.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.5M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$15.2M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$14.3M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$30.1M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$26.8M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$19.9M |
| 4 |
BlackRock
New York
|
-$18.5M |
| 5 |
EP
Eversept Partners
New York
|
-$14.9M |
OMCL Hedge Fund Activity: Q3 2021 in Review
386 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q3 2021, worth a combined $6.7B — down 0.1% from $6.71B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new OMCL positions and 26 closed out — a net gain of 13 holders — while 144 added to existing stakes and 148 trimmed.
The largest buyer was Invesco, adding an estimated $104M. The largest seller was Wellington Management Group, cutting an estimated $30.1M.
- 386 institutional investors held Omnicell (OMCL) as of Q3 2021, up from 377 in Q2 2021.
- Funds reported $6.7B of Omnicell stock for Q3 2021, down 0.1% quarter-over-quarter.
- 39 funds opened new Omnicell positions in Q3 2021 and 26 closed out, a net change of +13 holders.
- The largest Omnicell buyer in Q3 2021 was Invesco, an estimated $104M added.
- The largest Omnicell seller in Q3 2021 was Wellington Management Group, an estimated $30.1M sold.
Based on aggregated 13F filings for Q3 2021.